Indraprastha Medical Corporation Limited (INDRAMEDCO.NS) Valuation

Valuation

Model-based estimates, not advice. The DCF is the discounted-cash-flow value per share; compare it with the price, not as a target.

DCF fair value

+171.7%

₹863.31

vs ₹317.80 price

Levered DCF

₹559.12

After debt service

Piotroski score

4 / 9

Average

Altman Z-score

—

Rating

Overall 3 / 5

Ratios by fiscal year

Margins and yields are shares of revenue, equity or price; multiples are ×.

Metric	FY2026	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019
P/E	18.59×	22.38×	13.31×	8.2×	9.14×	214.8×	7.12×	12.89×
P/B	4.61×	6.04×	3.45×	1.86×	1.65×	1.8×	1.16×	1.5×
P/S	2.3×	2.66×	1.32×	0.64×	0.6×	0.8×	0.39×	0.48×
EV / EBITDA	11.65×	14.63×	7.82×	4.08×	4.25×	11.6×	3.7×	4.79×
Gross margin	34.1%	25.8%	25.1%	56.8%	53.9%	56.6%	55.8%	54.9%
Operating margin	15.1%	14.9%	12.5%	10.3%	9.7%	1.4%	6.8%	6.9%
Net margin	12.4%	11.9%	10.0%	7.8%	6.6%	0.4%	5.5%	3.7%
Current ratio	2.46×	2.41×	1.86×	1.72×	1.68×	1.22×	1.01×	1.09×
Debt / equity	0.05×	0.05×	0.07×	0.01×	0.02×	0.03×	0.05×	0.09×
Interest coverage	37.09×	32.34×	38.35×	26.44×	25.16×	2.54×	9.2×	7.63×
Dividend yield	1.2%	1.1%	1.7%	3.2%	0.0%	0.0%	5.7%	4.4%
Payout ratio	22.3%	25.3%	22.2%	26.5%	0.4%	10.5%	40.9%	56.7%

Key metrics by fiscal year

Metric	FY2026	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019
Return on equity	24.8%	27.0%	25.9%	22.7%	18.0%	0.9%	16.3%	11.6%
Return on invested capital	20.2%	22.4%	20.8%	19.4%	17.1%	1.4%	15.6%	11.3%
Return on assets	18.5%	18.9%	17.1%	15.5%	12.7%	0.5%	9.7%	6.7%
Free cash flow yield	3.8%	3.3%	7.9%	14.1%	7.8%	1.4%	14.7%	15.9%
Earnings yield	5.4%	4.5%	7.5%	12.2%	10.9%	0.5%	14.0%	7.8%
Enterprise value	₹34.5B	₹35.7B	₹16.2B	₹6.6B	₹5B	₹4.8B	₹3B	₹3.7B
Net debt / EBITDA	0.11×	-0.12×	-0.13×	-0.31×	-0.31×	-0.42×	-0.08×	0.06×
Cash conversion cycle (days)	-17	-22	-10	-11	-6	4	4	12